epoetin alfa,luspatercept,epoetin alfa
bms
['commands', 'lusp', 'commands trial', 'commands,(-recommands)', 'epoetin', 'mds']
happening now at #asco23: of is presenting efficacy and safety results from the phase iii commands trial, which evaluated luspatercept vs epoetin alfa in patients with lr-mds who are esa naive and transfusion dependent.
Translating Hematologic Oncology Discoveries into Practice.